“What we’re doing now is pushing the funding,” Institute Chairman Michael Milken recently told The Wall Street Journal. “Philanthropy is about 3% to 5% of all medical research, but it’s often what gets it going.”
For more insight on how Michael Milken and the Milken Institute are boosting research for COVID-19 through philanthropy, funding, and the Institute’s COVID-19 Treatment and Vaccine Tracker, read the May 1, 2020 coverage in The Wall Street Journal at the button below.